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OBJECTIVES We sought to assess the prognostic utility of brachial artery reactivity (BAR) in patients at risk
of cardiovascular events.
BACKGROUND Impaired flow-mediated vasodilation measured by BAR is a marker of endothelial dysfunc-
tion. Brachial artery reactivity is influenced by risk factors and is responsive to various
pharmacological and other treatments. However, its prognostic importance is uncertain,
especially relative to other predictors of outcome.
METHODS A total of 444 patients were prospectively enrolled to undergo BAR and follow-up. These
patients were at risk of cardiovascular events, based on the presence of risk factors or known
or suspected cardiovascular disease. We took a full clinical history, performed BAR, and
obtained carotid intima-media thickness (IMT) and left ventricular mass and ejection
fraction. Patients were followed up for cardiovascular events and all-cause mortality.
Multivariate Cox regression analysis was performed to assess the independent association of
investigation variables on outcomes.
RESULTS The patients exhibited abnormal BAR (5.2  6.1% [mean  SD]) but showed normal
nitrate-mediated dilation (9.9  7.2%) and normal mean IMT (0.67  0.12 mm [average]).
Forty-nine deaths occurred over the median follow-up period of 24 months (interquartile
range 10 to 34). Patients in the lowest tertile group of BAR (2%) had significantly more
events than those in the combined group of highest and mid-tertiles (p  0.029, log-rank
test). However, mean IMT (rather than flow-mediated dilation) was the vascular factor
independently associated with mortality, even in the subgroup (n  271) with no coronary
artery disease and low risk.
CONCLUSIONS Brachial artery reactivity is lower in patients with events, but is not an independent predictor
of cardiovascular outcomes in this cohort of patients. (J Am Coll Cardiol 2004;43:616–23)
© 2004 by the American College of Cardiology Foundations
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Un patients with coronary artery disease (CAD), coronary
ndothelial dysfunction has been shown to correlate with
ardiovascular events (1,2). However, the techniques used
or assessment of coronary reactivity are invasive and not
deal for clinical purposes, especially if serial measurements
re required. An alternative approach is to non-invasively
xamine vascular function in a peripheral vessel, in the belief
hat vascular disease is a systemic process (3,4). This
See page 624
rinciple underpins the non-invasive assessment of brachial
rtery reactivity (BAR) to measure flow-mediated dilation
FMD) of the arteries (5). A number of studies have shown
hat abnormal arterial reactivity is associated with the classic
ardiovascular risk factors (6,7) and that treatment of these
isk factors can improve endothelial function (8–10).
However, the prognostic power of this technique remains
oorly defined. The association between coronary and
rachial reactivity is modest to good (11,12). The existing
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his study was supported in part by grants from the National Heart Foundation of
ustralia and the National Health and Medical Research Council of Australia.
Manuscript received April 20, 2003; revised manuscript received September 11,003, accepted September 22, 2003.tudies investigating BAR and outcomes have generally
nvolved small or highly selected populations (13,14), and
hey have not addressed whether the test results provide
nformation that is incremental to that already gathered by
lternative tests. Therefore, we sought to investigate
hether the measurement of brachial artery FMD could
redict mortality and cardiovascular morbidity in a large
roup of patients at risk of vascular disease, and whether this
nformation was incremental to that already gathered in risk
ssessment.
ETHODS
tudy design. Consecutive patients deemed at risk of
AD were prospectively enrolled from cardiology and renal
utpatients from December 1998 to July 2002, for risk
valuation and subsequent follow-up. Patients were deemed
t risk due to known or suspected vascular disease, renal
ysfunction, or the presence of multiple cardiovascular risk
actors. Exclusion criteria included a recent (up to six weeks)
npatient stay due to myocardial infarction (MI), acute
oronary syndrome, coronary revascularization, heart failure,
r sepsis. All patients gave written, informed consent, and
he study was approved by the Human Ethics Committee of
niversity of Queensland and Princess Alexandra Hospital.
A full clinical history and examination were undertaken
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February 18, 2004:616–23 Vascular Structure, Function, and Outcomey a specialist physician. Baseline demographic data, car-
iovascular risk factors, and cardiovascular medications were
ocumented, and a 12-lead electrocardiogram was reviewed.
asting serum was collected for lipid analysis. Brachial
rtery reactivity was assessed as a measure of vascular
ysfunction; carotid intima-media thickness (IMT) was
easured as a marker of atherosclerotic burden; and stan-
ard transthoracic echocardiography was performed for
ssessment of left ventricular (LV) ejection fraction (EF)
nd mass.
linical evaluation. The presence of CAD was defined as
history of MI, coronary revascularization, or typical chest
ain with a positive stress echocardiogram. Diabetes melli-
us was defined by the use of insulin injections or oral
ypoglycemic agents. Hypertension was defined as an aver-
ge systolic blood pressure 140 mm Hg or diastolic blood
ressure 90 mm Hg on three separate occasions or by the
se of antihypertensive medications (15). Hypercholesterol-
mia was defined as a fasting total cholesterol level of 190
g/dl (4.90 mmol/l) (16) or by the use of a statin. Smoking
tatus was defined as current smoker or reformed/non-
moker. Significant renal impairment was defined as chronic
enal impairment, with a calculated glomerular filtration
ate of 60 ml/min/1.73 m2, or by dialysis (17).
Two-year coronary heart disease event risk in patients
ith no previous MI was calculated using the revised
ramingham risk score (18), using the variables of gender,
ge, total cholesterol, high-density lipoprotein (HDL) cho-
esterol, systolic blood pressure, and smoking status. For
atients with a previous MI, a two-year coronary heart
isease event rate was calculated from gender, age, total
holesterol, HDL cholesterol, systolic blood pressure, dia-
etes, and smoking history (19).
iochemical analysis. Blood for biochemical analysis was
btained from fasting venous samples. Total cholesterol,
DL cholesterol, and triglycerides were determined by
tandard enzymatic methods. High-density lipoprotein was
easured as a homogeneous assay in liquid phase. The
riedewald equation was used to calculate low-density
ipoprotein.
rachial artery reactivity. Our technique for assessment of
AR has been previously described (20). Patients were
tudied in the fasting state; vasoactive medications were
ithheld for 24 h before the study. After 5 min of rest, the
Abbreviations and Acronyms
BAR  brachial artery reactivity
CAD coronary artery disease
EF  ejection fraction
FMD flow-mediated dilation
HDL high-density lipoprotein
IMT  intima-media thickness
LV  left ventricle/ventricular
MI  myocardial infarctionrachial artery was located above the elbow, and a longitu- linal image of 6 to 8 cm was taken as the resting scan. A
lood pressure cuff was placed on the forearm and inflated
o 300 mm Hg for 4.5 min. The cuff was deflated, and after
1 min, the second or FMD scan was obtained, which
epresents the endothelial-dependent dilation due to shear-
nduced endothelial nitric oxide production. The second rest
can was acquired after 15 min of rest, and endothelial-
ndependent dilation was measured by calculation of the
asodilator response to exogenous nitrate 3 min after ad-
inistration of 400 g of sublingual nitroglycerin. The
ercent diameter change for FMD and nitrate-mediated
ilation was calculated in relation to its respective rest scan,
nd the ratio of flow-mediated to nitrate-mediated dilation
as also calculated. Thirty-eight randomly selected images
ere reanalyzed for intraobserver variation, using the pre-
iously described software developed for lumen measure-
ent (HDILab version 1.5, with the Lumen Diameter
ver Time version 1.15 plugin, HDI Lab, Bothell, Wash-
ngton). Intraobserver variation for FMD was 1.4  1.2%,
ith a coefficient of variation of 5.3%. For nitrate-mediated
ilation, the intraobserver variation was 2.1  1.8%, with a
oefficient of variation of 7.6%.
ntima-media thickness. Our method for IMT measure-
ent has been previously reported (21). Both the left and
ight common carotid arteries were imaged at the level of
he carotid bifurcation in the anterior, lateral, and posterior
lane, using longitudinal B-mode ultrasonography. The
ocal zone was set at or just below the far wall, which was
canned perpendicular to the transducer face. The far wall
MT was identified as the region between the lumen-intima
nterface and the media-adventitia interface; care was taken
o exclude localized plaque. Off-line analysis of magnified,
rozen end-diastolic images was performed by an experi-
nced observer with automatic edge-detection software
HDILab version 1.83H). Intraobserver variation in far wall
ean IMT was studied in 288 images using the automated
oftware. The intraobserver variation was 0.01  0.04 mm,
ith a coefficient of variation of 5.0%.
etection of ischemia. A subset of patients underwent
obutamine stress echocardiography with standard end
oints, as previously described (22). Wall motion was scored
sing the 16-segment model of the American Society of
chocardiography (23). Regional myocardial performance
as scored on the basis of wall thickening as normal, mildly
ypokinetic, severely hypokinetic, and akinetic or dyski-
etic. Ischemia was identified by new or worsening wall
otion abnormalities with stress.
ransthoracic echocardiography. Patients also underwent
tandard echocardiography. Ejection fraction was calculated
sing the modified Simpson’s biplane rule (23). Left ven-
ricular mass was calculated using the formula of Devereux
nd Reichek (24,25).
utcomes. The primary outcome was the time to the most
ignificant episode, in order, of death (26), MI, or admission
ith acute coronary syndrome, stroke, or coronary revascu-arization. In patients with more than one event, only the
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Vascular Structure, Function, and Outcome February 18, 2004:616–23ost significant event was used for analysis. Outcomes were
etermined by assessment of the death certificate or hospital
ecord survey or by telephone conversation with the patient
r treating local medical practitioner.
Acute coronary syndrome was defined as worsening of
ngina class or ischemic chest pain at rest of 30 min,
ecessitating hospital admission with either 1) ST-segment
eviation of at least 0.1 mV or new T-wave inversion in two
ontiguous leads; or 2) a creatine kinase rise greater than
wice the upper limit of normal. ST-segment elevation MI
as defined as ischemic chest pain at rest of 30 min, with
ew ST-segment elevation of at least 0.1 mV and a creatine
inase increment of 2 times the upper limit of normal.
tatistical analysis. All data are expressed as mean value
D or frequency (%), unless otherwise stated. The baseline
linical characteristics of the groups were compared using
he two-tailed independent t test for continuous variables
nd the chi-square or Fisher exact test for non-continuous
ariables, as appropriate. Survival was illustrated with
aplan-Meier curves, and outcomes were compared using
he log-rank test. Independent predictors of events were
Table 1. Patient Characteristics
C
(n 
Age (yrs) 64
Men 102
Body mass index (kg/m2) 28
Known or suspected CAD
Previous MI 126
Chest pain 150
Revascularization 46
Renal dysfunction
Dialysis 43
Chronic renal impairment 11
Transplant 13
Risk factors
Hyperlipidemia 86
Hypertension 106
Diabetes mellitus 55
Smoker (current) 11
Calculated 2-year risk of a cardiac event
4% (high risk) 110
4% (low to intermediate risk) 40
Lipids analysis
Total cholesterol (mg/dl) 177
LDL cholesterol (mg/dl) 99
HDL cholesterol (mg/dl) 41
Triglycerides (mg/dl) 199
Medications
Beta-blocker 100
ACE inhibitor 73
Calcium channel blocker 72
Statin 102
Nitrate 61
Aspirin 120
Insulin 8
Oral hypoglycemic agents 48
Data are presented as the mean value  SD or number (%)
ACE  angiotensin-converting enzyme; CAD  coro
low-density lipoprotein; MI  myocardial infarction.alculated using Cox proportional hazards regression. The Collowing variables were used first in a univariate model: age,
ender, presence of known or likely CAD, renal dysfunc-
ion, previous MI, hypertension, hyperlipidemia, diabetes
ellitus, current smoking, FMD, nitrate-mediated dilation,
ow to nitrate dilation ratio, IMT, total, low-density
ipoprotein, and HDL cholesterol, triglycerides, medica-
ions, LV mass, EF, and two-year risk score. Factors with a
alue of p  0.20 were then entered into a forward stepwise
ultivariate Cox proportional hazards analysis. Statistical
ignificance was assumed at p 0.05. All statistical analyses
ere performed using SPSS for Windows 11.0 (SPSS Inc.,
hicago, Illinois).
ESULTS
linical characteristics. We studied 444 patients (age 58
14 years; 265 men). The inclusion categories included
ultiple risk factors (n  160 [36%]), dialysis patients
ithout clinical evidence of CAD (n  134 [23%]), and
nown CAD (n  150 [34%]); the last group included 126
atients (28%) with previous MI and 60 (14%) with proven
)
Dialysis
(n  134)
Multiple Risk Factors
(n  160)
56  15 56  14
71 (53%) 92 (58%)
26  7 27  5
— —
) 17 (13%) 8 (5%)
— —
134 (100%) —
— 53 (33%)
— 79 (49%)
73 (55%) 76 (48%)
111 (83%) 87 (54%)
40 (30%) 33 (21%)
11 (8%) 13 (8%)
12 (9%) 11 (7%)
122 (91%) 149 (93%)
183  45 193  42
104  41 102  37
46  16 53  20
166  106 188  125
41 (31%) 46 (29%)
52 (39%) 68 (43%)
44 (33%) 89 (56%)
56 (42%) 71 (44%)
13 (10%) 25 (16%)
38 (28%) 30 (19%)
10 (8%) 7 (4%)
21 (16%) 9 (6%)
ients.
rtery disease; HDL  high-density lipoprotein; LDL AD
150
 11
(68%)
 6
(84%)
(100%
(31%)
(29%)
(7%)
(9%)
(57%)
(71%)
(37%)
(7%)
(73%)
(27%)
 44
 38
 15
 146
(67%)
(49%)
(48%)
(68%)
(41%)
(80%)
(5%)
(32%)
of pat
nary aAD not amenable to revascularization. Clinical details are
s
f
c
3
s
O
m
t
b
f
t
c
e
w
d
w
n
n

p
d
f
w
m
a
g
h
f
V
e
I
l
(
(
3
d
0
e
a
a
w
s
a
(
d
m
A
I
F
w
b
C
t
a
t
i
m
m
a
o
h
0
i
c
T
B
F
N
F
M
M
E
L
D
F
i
l
fl
619JACC Vol. 43, No. 4, 2004 Fathi et al.
February 18, 2004:616–23 Vascular Structure, Function, and Outcomeummarized in Table 1. There was a high prevalence of risk
actors, as well as vasoactive and statin medications. The
alculated risk of a cardiac event over a two-year period was
.9  4.4%. The results of cardiac and vascular imaging are
ummarized in Table 2.
utcome. The median duration of follow-up was 24
onths (interquartile range 10 to 34). Complete informa-
ion on outcomes was obtained in 437 patients (98%). The
aseline characteristics of the seven patients without
ollow-up outcome analysis were not different from those of
he remainder. The 70 events included 49 deaths (33
ardiovascular), 13 MIs, 1 stroke (leading to death), and 8
pisodes of revascularization. Of the 70 events, 35 (50%)
ere in patients with CAD, 25 (36%) were in patients on
ialysis without previous evidence of CAD, and 10 (14%)
ere in patients with multiple risk factors. The causes of
on-cardiac death included complications of end-stage re-
al disease (n 4), septicemia (n 4), respiratory failure (n
2), palliation for neoplasm (n  2), meningitis (n  1),
eritonitis (n  1), gangrene due to peripheral vascular
isease (n  1), and ischemic hepatitis (n  1).
The calculated two-year cardiac risk score was 7.8  4.6%
or patients with CAD, 1.8  1.7% for dialysis patients
ithout previous MI, and 1.8  1.5% for patients with
ultiple cardiovascular risk factors. The corresponding
ctual cardiovascular mortality event numbers (% within
roup) were 13 (9%), 14 (10%), and 6 (4%), revealing a
igher than expected rate in the dialysis and multiple risk
actor groups.
ascular factors and outcome. Event-free survival was
xpressed using Kaplan-Meier curves based on tertiles of
MT, LV mass, and FMD (Fig. 1), of which IMT corre-
ated best with the outcome. The FMD tertiles included low
2% dilation), intermediate (2.1 to 6.3%), and high
6.3%), with corresponding two-year event numbers being
2, 17, and 21. Log-rank analysis revealed a significant
ifference between the low and intermediate tertiles (p 
.037). Further analysis revealed a significant difference in
vent rate between those with the most severe FMD
bnormality (tertile 1) and the combined group of second
nd third tertiles (log-rank p  0.029). When this analysis
as restricted to all-cause mortality alone, it remained
ignificant (log-rank p  0.047).
Cardiovascular events were independently associated with
able 2. Imaging Investigation Results
rachial artery diameter at rest (mm) 3.3  1.6
low-mediated dilation (%) 5.2  6.1
itroglycerin-mediated dilation (%) 9.9  7.2
low to nitroglycerin-mediated dilation ratio 0.68  1.4
ean carotid IMT (mm) 0.67  0.12
aximum carotid IMT (mm) 0.76  0.16
jection fraction (%) 57  15
eft ventricular mass (g) 253  116
ata are presented as the mean value  SD.
IMT  intima-media thickness.verage IMT, LV mass, nitrate use, and presence of angina lmodel chi-square 22.2, p  0.001) (Table 3). Cardiac
eath was independently associated with average IMT, LV
ass, and nitrate use (model chi-square 18.9, p  0.001).
ll-cause death was independently associated with average
MT and LV mass (model chi-square 16.1, p  0.001).
low-mediated dilation was not independently associated
ith outcome, and no significant interaction was found
etween FMD and IMT, LV mass, and EF.
linical correlates of adverse events. To further elucidate
he factors associated with events, the cohort was subdivided
ccording to the presence or absence of known CAD and
heir respective two-year risk for a coronary event. Univar-
ate predictors of an event are displayed in Table 4. A
ultivariate model was produced in the subgroups with
ore than one univariate predictor (CAD with risk 4%
nd no CAD with risk 4%). The independent predictors
f an event for CAD in the high-risk group included
yperlipidemia and nitrate use (model chi-square 10.6, p 
.005). For the group with no CAD and low risk, the
ndependent predictors were average IMT and EF (model
hi-square 31.0, p  0.001). Independent predictors in the
igure 1. Kaplan-Meier curves for event-free survival associated with (A)
ntima-media thickness (lowest tertile0.62 mm, highest0.71 mm), (B)
eft ventricular mass (lowest tertile 181 g, highest 276 g), and (C)
ow-mediated dilation (lowest tertile 2%, highest 6.3%).ow-risk population alone were average IMT, LV mass,
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Vascular Structure, Function, and Outcome February 18, 2004:616–23revious MI, and aspirin use (model chi-square 30.0, p 
.001). In the high-risk group, nitrate use remained predic-
ive (model chi-square 9.4, p  0.009).
A further univariate analysis based on clinical presenta-
ion (subsets of CAD, dialysis patients without previous
I, and those with multiple risk factors) is displayed in
able 5. Multivariate predictors of an event in groups with
ore than one univariate predictor revealed that in patients
ith CAD, independent predictors included hypertension
nd the use of beta-blockers, nitrates, and statins (model
hi-square 27.8, p 0.001). For patients on dialysis without
AD, they included IMT, EF, age, and the use of hypo-
lycemic tablets (model chi-square 35.4, p  0.001). For
atients with multiple risk factors, LV mass remained
ndependently significant (model chi-square 6.5, p  0.02).
schemia and adverse events. Patients undergoing stress
esting as well as vascular imaging had a higher calculated
wo-year risk score for a cardiac event (4.1 4.4% vs. 3.2
.5%, p  0.02), and 124 (45%) of 277 developed ischemia.
n this subset, univariate predictors of an event (hazard
atio, 95% confidence interval) included ischemia (2.5, 1.4
Table 3. Univariate and Multivariate Predictor
Variable HR
Age (yrs) 1.03
Male gender 0.84
Known or suspected CAD
Previous MI 2.13
Chest pain 2.36
Revascularization 0.74
Renal dysfunction
Dialysis 1.13
Pre-dialysis 0.62
Transplant 0.32
Two-year risk score (%) 1.08
Hypertension 1.63
Hyperlipidemia 1.06
Diabetes mellitus 1.62
Current smoker 0.58
Beta-blocker 1.05
Calcium channel blocker 1.30
ACE inhibitor 1.12
Long-acting nitrate 2.35
Statin 1.35
Aspirin 1.77
Oral hypoglycemic 2.02
Insulin 1.30
Total cholesterol 1.00
LDL cholesterol 1.00
HDL cholesterol 1.01
Triglycerides 1.00
Flow-mediated dilation (%) 0.96
Nitrate-mediated dilation (%) 0.97
Flow to nitrate ratio 1.01
Average IMT (per one-tenth mm increase) 1.37
Left ventricular mass (per 10 g) 1.02
Ejection fraction (%) 0.98
CI  confidence interval; HR  hazards ratio; other abbrevo 4.4; p  0.002), age (1.03, 1.01 to 1.05; p  0.01), srevious MI (2.0, 1.2 to 3.5; p  0.01), diabetes mellitus
2.1, 1.2 to 3.6; p  0.009), hypoglycemic tablets (2.4, 1.3
o 4.3; p  0.004), nitrate use (2.2, 1.3 to 3.9; p  0.005),
spirin use (2.0, 1.1 to 3.6; p  0.02), two-year risk score
1.08, 1.03 to 1.13; p  0.003), FMD (0.93, 0.87 to 0.98;
 0.01), nitrate-mediated dilation (0.95, 0.92 to 0.99; p
.01), IMT (1.5, 1.2 to 1.8; p  0.001), LV mass (1.03,
.01 to 1.05; p  0.02), and EF (0.98, 0.96 to 0.99; p 
.005). The independent predictors of an event in this
ubgroup included previous MI, nitrate use, FMD, IMT,
nd LV mass (model chi-square 33.8, p  0.001).
ISCUSSION
n a group of patients with significant risk of cardiovascular
vents, those with the most severe disturbance of FMD had
reater subsequent cardiac morbidity and mortality than
hose with normal or mildly abnormal FMD. However,
ortality was independently predicted by IMT and LV
ass rather than FMD. In the subgroup of patients with no
AD and low risk of an event, in whom further risk
ny Event by Cox Regression
nivariate Multivariate
% CI)
p
Value HR (95% CI)
p
Value
–1.05) 0.004 — —
–1.3) 0.48 — —
–3.41) 0.002 — —
–3.95) 0.001 1.94 (1.02–3.71) 0.04
–1.64) 0.46 — —
–1.84) 0.62 — —
–1.37) 0.23 — —
–1.35) 0.12 — —
–1.13) 0.001 — —
–2.98) 0.11 — —
–1.70) 0.81 — —
–2.60) 0.052 — —
–1.60) 0.29 — —
–1.68) 0.85 — —
–2.08) 0.27 — —
–1.92) 0.45 — —
–3.79) 0.001 2.18 (1.14–4.19) 0.02
–2.18) 0.21 — —
–2.85) 0.02 — —
–3.38) 0.008 — —
–3.00) 0.54 — —
–1.00) 0.30 — —
–1.00) 0.43 — —
–1.02) 0.89 — —
–1.01) 0.86 — —
–1.01) 0.07 — —
–0.99) 0.04 — —
–1.18) 0.86 — —
–1.63) 0.001 1.35 (1.07–1.69) 0.01
–1.04) 0.09 1.03 (1.01–1.05) 0.03
–0.99) 0.004 — —
s as in Tables 1 and 2.s of A
U
(95
(1.01
(0.53
(1.33
(1.40
(0.34
(0.70
(0.28
(0.08
(1.03
(0.89
(0.66
(1.01
(0.21
(0.65
(0.81
(0.75
(1.45
(0.84
(1.10
(1.20
(0.56
(0.99
(0.99
(0.99
(1.00
(0.92
(0.94
(0.87
(1.14
(0.99
(0.96
iationtratification might be most useful, average IMT and EF
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February 18, 2004:616–23 Vascular Structure, Function, and Outcomeere the independent predictors of an event. The only
ubgroup in which FMD proved to be an independent
redictor of events (along with IMT and LV mass) was that
hich had also undergone stress testing.
mportance of vascular dysfunction. The endothelium
xerts control over vascular tone and function through the
nfluence of paracrine substances that aid in the develop-
ent of an anti-atherogenic milieu with the inhibition of
latelet aggregation, smooth muscle cell proliferation, and
eukocyte adhesion (27). Abnormalities of endothelial func-
ion, and hence vascular dysfunction, commence at an early
ge and precede the development of overt atherosclerosis
5). Endothelial dysfunction is influenced by cardiovascular
isk factors (28) and has been shown to be influenced by
herapy.
Although significant prognostic information can be de-
ermined by coronary angiography (29,30), this technique
oes not assess the functional reactivity of the vessels.
urthermore, angiography is invasive and may miss signif-
cant atherosclerosis present in the vessel wall before even-
ual encroachment on the lumen occurs (31). An assessment
f vessel function may give additive prognostic information
o that derived from angiography.
ascular reactivity and outcome. Vascular responsiveness
as been shown to correlate with outcome. Scha¨chinger et
l. (1) demonstrated a greater incidence of cardiovascular
vents (cardiovascular death, unstable angina, MI, revascu-
arization, and ischemic stroke) in patients with an abnor-
al coronary vascular response to acetylcholine or nitroglyc-
rin, thus providing the first evidence of the prognostic
able 4. Univariate Predictors of an Event Based on the Presenc
Risk of CAD
<4%
(n  40)
>4%
(n  110)
Event Rate (%) 9 (23) 26 (24)
Variable HR
p
Value HR
p
Value H
wo-year risk score 2.9 0.028 — — —
ypertension — — 4.2 0.05 —
ypercholesterolemia — — 0.4 0.02 —
itrate use — — 2.8 0.015 —
ge — — — — 1.
ypoglycemic medication — — — — 2.
spirin use — — — — 2.
itrate-mediated dilation — — — — 0.
eft ventricular mass — — — — 1.
jection fraction — — — — 0.
eta-blocker use — — — — —
spirin use — — — — —
revious MI — — — — —
DL cholesterol — — — — —
low-mediated dilation 1.01 0.75 0.97 0.39 0.
MT 1.4 0.28 0.98 0.92 1.
bbreviations as in Tables 1 to 3.ignificance of coronary vascular dysfunction. In patientsith mild CAD, Suwaidi et al. (2) demonstrated no cardiac
vents (cardiac death, MI, and revascularization) in those
ith normal or mild coronary endothelial dysfunction,
hereas those with severe endothelial dysfunction had a
4% cardiac event rate (p  0.05 vs. normal endothelial
unction).
Because brachial artery FMD correlates with coronary
eactivity (11,12), similar results might be expected, but this
vidence base is not well established. In a study of 73
atients undergoing coronary angiography for the investi-
ation of chest pain, brachial FMD 10% was associated
ith increased cardiovascular events over a mean follow-up
eriod of five years (50% vs. 15%, p  0.002) (13). Another
tudy looked at the cardiovascular event rate in 400 post-
enopausal hypertensive women according to their level of
mprovement of brachial artery FMD after treatment for
ypertension (14). Over a mean follow-up period of 67
onths, event rates were lower in patients whose FMD
mproved after six months of treatment for hypertension
0.5 per 100 person-years), compared with those who did
ot show an improvement (3.5 per 100 person-years, p 
.0001). A short-term study involving a high-risk group of
atients undergoing vascular surgery (32) showed lower
MD in those with an event (4.9  3.1% vs. 7.3  5.0%,
 0.001), which remained an independent predictor (p 
.007).
Others have used forearm plethysmography for assess-
ent of peripheral vascular function. Perticone et al. (33)
ubclassified a group of 225 hypertensive patients into
ertiles on the basis of their forearm blood flow response to
cetylcholine. After a mean follow-up of 31.5 months, there
oronary Disease and Two-Year Risk of a Cardiac Event
No CAD Risk Whole Group Risk
4%
271)
>4%
(n  23)
>4%
(n  311)
>4%
(n  133)
(10) 7 (30) 37 (12) 33 (25)
p
Value HR
p
Value HR
p
Value HR
p
Value
— — — 1.3 0.03 — —
— — — — — — —
— — — — — — —
— — — — — 2.5 0.01
0.035 — — 1.03 0.009 — —
0.04 — — — — — —
0.029 — — — — — —
0.026 — — 0.95 0.02 — —
0.003 — — 1.03 0.013 — —
0.001 — — — — — —
— 5.9 0.02 — — — —
— — — 1.9 0.048 — —
— — — 2.7 0.025 — —
— — — — — 0.99 0.05
0.10 0.91 0.33 0.97 0.24 0.96 0.21
0.001 1.1 0.72 1.6 0.001 1.01 0.96e of C
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ertile with the poorest response (57%) than in those with
he greatest response (14%, p  0.0012). Similarly, in a
tudy of 276 patients being investigated for CAD, lower
cetylcholine-induced forearm blood flow was predictive of
ncreased event rates over a mean period of 4.5 years, which
lso remained an independent predictor in a Cox propor-
ional hazards model (34). However, the results of forearm
lethysmography and FMD are not necessarily analogous
35); venous dilation during plethysmography is less nitric
xide-dependent than arterial dilation. Of the two tech-
iques, only FMD is truly non-invasive and may be more
uited to clinical practice.
tudy limitations. This cohort of patients was at rela-
ively high risk, reflecting the recruitment of the group
rom a tertiary referral hospital with a high volume of
enal failure and renal transplant patients. These results
ay not be generalizable to patients in primary-care
ettings. However, although there were a large number of
vents in the dialysis population, the subgroup analysis of
hose at low risk and without CAD also showed FMD to
ack independent predictive value. Furthermore, though
he mean group FMD and nitrate-mediated dilation were
elatively low (5.2  6.1% and 9.9  7.2%, respectively),
he results are analogous to other studies of patients with
able 5. Univariate Predictors of an Event Based on the Presenc
CAD
(n  150)
Event Rate (%) 35 (23)
Variable HR (95% CI) p V
ge (yrs) 1.00 (0.98–1.04) 0
ale gender 0.56 (0.29–1.09) 0
wo-year risk score (%) 1.05 (0.98–1.12) 0
ypertension 2.71 (1.05–6.99) 0
yperlipidemia 0.83 (0.42–1.61) 0
iabetes mellitus 1.41 (0.73–2.74) 0
urrent smoker 1.02 (0.31–3.33) 0
eta-blocker 0.47 (0.24–0.91) 0
alcium channel blocker 1.69 (0.86–3.33) 0
CE inhibitor 1.64 (0.83–3.23) 0
ong-acting nitrate 2.76 (1.37–5.55) 0
tatin 0.55 (0.28–1.08) 0
spirin 0.60 (0.29–1.26) 0
ral hypoglycemic 1.41 (0.72–2.78) 0
nsulin 1.04 (0.25–4.35) 0
otal cholesterol 1.00 (0.99–1.01) 0
DL cholesterol 0.99 (0.98–1.00) 0
DL cholesterol 1.01 (0.99–1.03) 0
riglycerides 1.00 (1.00–1.01) 0
low-mediated dilation (%) 0.99 (0.93–1.04) 0
itrate-mediated dilation (%) 0.99 (0.95–1.04) 0
low to nitrate ratio 1.07 (0.88–1.30) 0
verage IMT (per one-tenth mm increase) 1.06 (0.80–1.40) 0
eft ventricular mass (per 10 g) 0.99 (0.96–1.03) 0
jection fraction (%) 1.00 (0.97–1.02) 0
bbreviations as in Tables 1 to 3.AD (13,36). (To permit a definite statement regarding incremental
rognostic data from BAR over coronary angiography, a
arge study of patients undergoing coronary angiography
ould be required, and thus the patient cohort would be
ifferent from that used in this study. The performance of
oronary angiography was not clinically indicated for the
ajority of patients.
Our only measure of carotid atherosclerosis was that of
MT with plaque being specifically excluded. It is possible
hat measures such as plaque extent may have revealed
ifferent (possibly stronger) associations with cardiovascular
vents.
This study used baseline investigations only. It would
ave been of interest if our imaging and biochemical
nvestigations were repeated and an assessment was made as
o whether changes in these variables had any effect on
utcomes. This has been attempted before by Modena et al.
14) in postmenopausal hypertensive women. It would also
ave been of interest to have assessed other biochemical risk
arameters such as apolipoprotein B, lipoprotein(a), and
igh-sensitivity C-reactive protein.
linical implications. Although the non-invasive nature
f BAR makes this feasible for serial measurements and
ong-term studies, its variability in response to acute stimuli
oronary Artery Disease, Dialysis, or Multiple Risk Factors
Dialysis Without CAD
(n  134)
Multiple Risk Factors
(n  160)
25 (19) 10 (6)
HR (95% CI) p Value HR (95% CI) p Value
1.04 (1.01–1.07) 0.007 1.02 (0.97–1.07) 0.40
1.00 (0.45–2.18) 0.99 1.41 (0.36–5.47) 0.62
1.16 (0.94–1.43) 0.16 1.21 (0.86–1.71) 0.27
1.63 (0.49–5.44) 0.43 0.49 (0.14–1.76) 0.28
1.43 (0.63–3.24) 0.39 0.91 (0.25–3.33) 0.89
1.54 (0.69–3.42) 0.29 1.95 (0.49–7.74) 0.34
0.04 (0.01–18.5) 0.31 0.70 (0.09–5.61) 0.74
1.53 (0.69–3.42) 0.30 1.52 (0.39–6.00) 0.55
0.82 (0.34–2.00) 0.66 1.66 (0.46–6.07) 0.44
0.71 (0.31–1.65) 0.43 1.07 (0.30–3.85) 0.92
1.24 (0.37–4.15) 0.73 1.21 (0.26–5.79) 0.81
3.18 (1.37–7.37) 0.007 1.01 (0.28–3.67) 0.98
2.65 (1.21–5.81) 0.02 2.26 (0.55–9.28) 0.26
2.82 (1.17–6.79) 0.02 0.04 (0.01–3651) 0.59
1.59 (0.47–5.29) 0.46 2.71 (0.30–24.84) 0.38
1.00 (0.99–1.01) 0.91 0.99 (0.97–1.01) 0.19
1.01 (1.00–1.02) 0.30 0.98 (0.96–1.01) 0.18
0.99 (0.96–1.02) 0.38 1.01 (0.98–1.05) 0.42
1.00 (0.99–1.00) 0.18 1.00 (1.00–1.01) 0.93
0.94 (0.87–1.01) 0.08 0.91 (0.77–1.08) 0.29
0.95 (0.90–1.00) 0.07 0.94 (0.84–1.04) 0.23
0.93 (0.68–1.27) 0.65 0.67 (0.20–2.30) 0.53
1.81 (1.31–2.49) 0.001 1.34 (0.83–2.17) 0.23
1.04 (1.01–1.07) 0.03 1.05 (1.01–1.10) 0.02
0.96 (0.94–0.98) 0.001 1.03 (0.94–1.12) 0.56e of C
alue
.77
.09
.15
.04
.57
.31
.98
.03
.13
.15
.004
.08
.18
.32
.96
.58
.08
.22
.39
.58
.68
.52
.68
.65
.8037) has made it more useful for group and intergroup
a
t
b
a
r
e
g
F
p
e
A
W
t
R
w
c
t
R
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
623JACC Vol. 43, No. 4, 2004 Fathi et al.
February 18, 2004:616–23 Vascular Structure, Function, and Outcomenalyses in research rather than clinical applications. Al-
hough the current study shows that abnormal FMD in the
rachial artery provides prognostic information on mortality
nd cardiovascular events in patients at moderate levels of
isk, this information does not appear to be incremental to
xisting clinical and imaging data. However, in the sub-
roup of higher risk patients undergoing stress testing,
MD along with measures of structure (IMT and LV mass)
roved to be an independent predictor of cardiovascular
vents.
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